In vitro evaluation of Plasma Activated Hydrogels (PAH) in combination with chemotherapeutic drugs on vulvar cancer
Geburtshilfe und Frauenheilkunde · 01.10.2024 · 84 (10) · e218
DOI: 10.1055/s-0044-1790959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.10.2024. Verfasst von E. Schad und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
Vulvar cancer represents 4% of gynecological malignancies worldwide. Current treatment options including surgery and chemotherapy have various negative side effects. Cold atmospheric plasma (CAP), described as a partially ionized gas, has recently become an important tool for cancer treatment. Due to the reactive oxygen and nitrogen species (RONS), oxidative stress can be induced in cancer cells which leads to apoptosis and immunogenic cell death. To control the area of application and to prolong the interaction between RONS and the tissue, CAP can be delivered as Plasma Activated Hydrogel (PAH). Materials and methods: PAH was generated using the VIO3 / APC3 electrosurgical argon plasma device (Erbe Elektromedizin, Tübingen) and evaluated assay-based towards cell viability, apoptosis and scavenging pathways on the vulvar cancer cell line SW954 in-vitro.
Results
PAH treatment of SW954 significantly diminished cell viability. PAH combined with the chemotherapeutic Paclitaxel and 5-Fluoruracil showed no synergistic enhancement of PAHs anti-cancer efficacy. Combination with Cisplatin, a cytostatic drug that causes DNA damage and apoptosis induction, showed a synergistic effect towards cytotoxicity. Apoptosis induction was detected by measuring an elevated activity of Caspase 3/7. Prior PAH treatment followed by cisplatin treatment showed a stronger cytotoxicity contrary to the reversed way. Combination therapy showed a stronger decrease of glutathione compared to PAH only. The absence of glutathione scavenging of RONS enhances the cytotoxic effects on cancer cells.
Conclusion
The observed synergy between PAH and cisplatin could be a valuable tool for reducing the necessity for high-dose chemotherapy and for overcoming chemotherapeutic resistances. Publication History Article published online: 01 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Schad, E., Decool, H., & Weiss, M. (2024). In vitro evaluation of Plasma Activated Hydrogels (PAH) in combination with chemotherapeutic drugs on vulvar cancer. Geburtshilfe und Frauenheilkunde, 84(10), e218. https://doi.org/10.1055/s-0044-1790959
Vancouver
Schad E, Decool H, Weiss M. In vitro evaluation of Plasma Activated Hydrogels (PAH) in combination with chemotherapeutic drugs on vulvar cancer. Geburtshilfe und Frauenheilkunde. 2024;84(10):e218. doi:10.1055/s-0044-1790959
BibTeX
@article{Schad2024,
author = {Schad, E. and Decool, H. and Weiss, M.},
title = {In vitro evaluation of Plasma Activated Hydrogels (PAH) in combination with chemotherapeutic drugs on vulvar cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2024},
volume = {84},
number = {10},
pages = {e218},
doi = {10.1055/s-0044-1790959}
}
EUVIMED